Harel Insurance Investments & Financial Services’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-6
| Closed | – | – | 556 |
|
|
2019
Q4 | $0 | Buy |
+6
| New | – | ﹤0.01% | 585 |
|
|
2018
Q4 | – | Sell |
-39,000
| Closed | -$180K | – | 552 |
|
|
2018
Q3 | $180K | Hold |
39,000
| – | – | 0.01% | 212 |
|
|
2018
Q2 | $179K | Hold |
39,000
| – | – | 0.01% | 194 |
|
|
2018
Q1 | $281K | Hold |
39,000
| – | – | 0.02% | 180 |
|
|
2017
Q4 | $328K | Hold |
39,000
| – | – | 0.02% | 169 |
|
|
2017
Q3 | $328K | Hold |
39,000
| – | – | 0.03% | 134 |
|
|
2017
Q2 | $398K | Hold |
39,000
| – | – | 0.03% | 122 |
|
|
2017
Q1 | $460K | Sell |
39,000
-17,000
| -30% | -$201K | 0.04% | 93 |
|
|
2016
Q4 | $717K | Buy |
56,000
+5,000
| +10% | +$64K | 0.1% | 62 |
|
|
2016
Q3 | $510K | Buy |
51,000
+15,000
| +42% | +$150K | 0.07% | 77 |
|
|
2016
Q2 | $396K | Buy |
+36,000
| New | +$396K | 0.05% | 102 |
|